PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers discover new genetic factors associated with successful aging in the Amish

New findings on mitochondrial haplogroups and genetic variants that positively affect the aging process to be presented at ASHG 60th Annual Meeting in Washington, D.C.

2010-11-04
(Press-News.org) BETHESDA, MD – October 15, 2010 – Thousands of the world's top scientists and clinicians in the human genetics field will convene to present their latest research findings at the American Society of Human Genetics (ASHG) 60th Annual Meeting, on November 2-6, 2010, in Washington, D.C.

A number of the scientific papers presented at the ASHG 2010 meeting will provide information about important new research findings in statistical genetics and genetic epidemiology. One such research abstract of interest on these topics titled, "Mitochondrial Haplogroup X is Associated with Successful Aging in the Amish," will be featured in a platform session that will take place on Friday, November 5, 2010, from 1:30-4:00 p.m. at the Walter E. Washington Convention Center. A brief summary of the research findings from this abstract is included in the section below:

Mitochondrial Haplogroup X is Associated with Successful Aging in the Amish

Avoiding disease, maintaining physical and cognitive function, and continuing social engagement in late life are considered to be key factors associated with what some gerontologists call "successful aging." While conducting studies of Amish families in Indiana and Ohio, a group of researchers led by William K. Scott, PhD, Professor of Human Genetics at the University of Miami Miller School of Medicine, began to notice that a significant number of people over age 80 in these communities demonstrated the three main factors associated with successful aging. In the current study, Scott and his colleagues investigated the genetic differences between Amish individuals who had successfully aged compared with individuals from the general population to see what genetic factors are keeping them healthier and happier well into their later years.

A total of 263 volunteers, age 80 and older, were enrolled in a population-based door-to-door survey of Amish communities in Indiana and Ohio. The researchers studied this particular Amish population because they have fairly large families with well-documented genealogies. Furthermore, because they live relatively homogeneous lives, non-genetic factors such as environment and diet would have a smaller effect on successful aging, as compared to the general population. Study participants who scored in the top third of the sample for lower limb function, required little assistance with self-care tasks, had no symptoms of depression, and expressed a high level of life satisfaction were considered to be 'successfully aged' (73 participants in total). The remaining 190 study participants were retained as controls.

Researchers have theorized for some time that mitochondria – the organelles that produce energy in human cells – may play a role in aging. There is evidence that people who age successfully have genetically different mitochondria when compared to the general population. Furthermore, mitochondrial lineages described by patterns of common genetic variants (or "haplogroups") have also been shown to be associated with increased longevity in different populations. To better understand these underlying genetic factors, Dr. Scott and his colleagues studied the influence of mitochondrial haplogroups on successful aging and sought to identify the common genetic variations in the mitochondrial genome that are potentially associated with successful aging in a sample of Amish individuals age 80 and older.

The common variations in the mitochondrial genome define distinct 'haplogroups that are found in specific geographic regions around the world. For this study, Scott's research team looked at the nine most common European haplogroups, since the Amish are descendants of individuals from Europe.

The current research results indicate that one fairly rare mitochondrial haplogroup found in only 2% of all Europeans – which is known as 'haplogroup X' – was found in 15% of the successfully aged Amish population (versus only 3% of the controls) and had a significant positive association with successful aging. On the other hand, the researchers also reported that another mitochondrial haplogroup called 'haplogroup J' which is typically found in about 10-25% of Southern Europeans, was found in only 5% of the Amish population and had a negative association with successful aging factors.

Thus, a significant positive association with successful aging was found with mitochondrial haplogroup X (which was more prevalent among the successfully aged Amish population), while a negative association was found with haplogroup J (which is more prevalent in European populations than the Amish). All positively associated alleles were found together on haplogroup X, while all negatively associated alleles fell in haplogroup J. All positively associated alleles were found together on haplogroup X (1719A), while all negatively associated alleles fell in haplogroup J (rs2854122, rs3135030, and 10398G). These data represent a novel association of mitochondrial haplogroup X with successful aging that conflicts with previous positive associations of haplogroup J with longevity in other populations.

"In this study, we focused on looking for genes that may have an influence on keeping people healthy, rather than identifying genes associated with disease," said William Scott, PhD, the senior author of the research abstract presented at the ASHG 2010 Annual Meeting. "Our research results support the idea that mitochondria play an important role in aging, and our findings also suggest a specific subset of genetic variants that might influence successful aging in this group of people."

"In our future research, it is important that we attempt to broadly associate this mitochondrial variation to aging in this population, figure out what it does biologically, and then see if we can reproduce it in other samples," said Scott. "Furthermore, we will also need to look more closely at the mitochondrial genome for specific variants that influence aging."

### PRESS REGISTRATION FOR ASHG 2010 MEETING

If you wish to register to attend the ASHG 2010 Annual Meeting as a member of the press, please complete the online press pre-registration form at the following link by the deadline on October 25, 2010: http://www.ashg.org/2010meeting/pages/press_register.shtml. For all other media inquiries, contact Kristen Long, ASHG Communications Manager, via e-mail at klong@ashg.org, or call 240-281-2386.

ABOUT THE AMERICAN SOCIETY OF HUMAN GENETICS

Founded in 1948, the American Society of Human Genetics (ASHG) is the primary professional membership organization for human genetics specialists worldwide. The nearly 8,000 members of ASHG include researchers, academicians, clinicians, laboratory practice professionals, genetic counselors, nurses and others with a special interest in human genetics. The Society's mission is to serve research scientists, health professionals and the public by providing forums to: (1) share research results through the Annual Meeting and in The American Journal of Human Genetics (AJHG); (2) advance genetic research by advocating for research support; (3) educate future genetics professionals, health care providers, advocates, teachers, students and the general public about all aspects of human genetics; and (4) promote genetic services and support responsible social and scientific policies. For more information about ASHG, please visit http://www.ashg.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

Vulnerable brain region may be central to progression of Alzheimer's disease

2010-11-04
New research is helping to unravel the events that underlie the "spread" of Alzheimer's disease (AD) throughout the brain. The research, published by Cell Press in the November 4th issue of the journal Neuron, follows disease progression from a vulnerable brain region that is affected early in the disease to interconnected brain regions that are affected in later stages. The findings may contribute to design of therapeutic interventions as targeting the brain region where AD originates would be simpler than targeting multiple brain areas. An alteration in brain levels ...

Plasticity supports cognitive recovery after brain damage

2010-11-04
New research provides fascinating insight into mechanisms that underlie recovery after damage to a region of the brain important for memory and attention. The research, published by Cell Press in the November 4th issue of the journal Neuron, highlights the role of undamaged portions of the brain that can "take over" and support the recovery of function. Brain damage can have devastating consequences, depending on the location and severity of the injury. Damage to an area of the brain called the prefrontal cortex often results in deficits in memory and attention. However, ...

Armed antibody triggers remissions for Hodgkin's lymphoma

2010-11-04
HOUSTON ― An antibody loaded with an anti-cancer agent produced complete or partial remissions in 38 percent of patients with relapsed or therapy-resistant Hodgkin lymphoma enrolled in a phase I clinical trial, investigators report in the Nov. 4 issue of the New England Journal of Medicine. "That level of objective responses to a drug is impressive for a Phase I trial," said study lead author Anas Younes, M.D., professor in The University of Texas MD Anderson Cancer Center's Department of Lymphoma/Myeloma. "These encouraging results are being confirmed in a large ...

Combining radiation therapy, chemotherapy safely treats head and neck cancer patients

2010-11-04
SAN DIEGO, Nov. 3 – Stereotactic body radiotherapy (SBRT), a radiation therapy procedure pioneered at the University of Pittsburgh Cancer Institute (UPCI) that precisely delivers a large dose of radiation to tumors, may effectively control and treat head and neck cancers when combined with the chemotherapy Cetuximab, according to researchers from UPCI. The results of the research will be presented today at the American Society for Radiation Oncology (ASTRO) annual meeting in San Diego. The study, led by Dwight E. Heron, M.D., professor of otolaryngology and vice chairman ...

Higher medication spending doesn't indicate better prescribing quality

2010-11-04
PITTSBURGH, Nov. 3 – Medicare patients in regions that spend the most on prescription medications are not necessarily getting better quality care, according to a new study of spending practices from the University of Pittsburgh Graduate School of Public Health (GSPH). The findings, published in the Nov. 3 Online First issue of the New England Journal of Medicine, reveal great variation across the country in both drug spending and the rate of inappropriate prescriptions for the elderly. Lead investigator Yuting Zhang, Ph.D., assistant professor of health economics at GSPH, ...

Study shows drop in unnecessary care after Medicare reimbursement cut

2010-11-04
ANN ARBOR, Mich. — When Medicare policy changes led to reductions in reimbursement for hormonal treatment of prostate cancer, there was a sharp decline in its use among patients not likely to benefit from the treatment. But among patients for whom the therapy is clearly beneficial, doctors continued to prescribe it at the same rate, according to a new study. This finding suggests that financial reform of health care can reduce unnecessary care without impacting care to those patients most likely to benefit from a treatment. "We found that physicians respond to reimbursement, ...

Meta-flex: Your new brand for invisibility clothing

2010-11-04
Flexible smart materials that can manipulate light to shield objects from view have been much-theorised but now researchers in Scotland have made a practical breakthrough that brings the possibility of an invisibility cardigan – or any other item of invisibility clothing - one step closer. Two challenges to the creation of smart flexible materials that can cloak from visible light are making meta-atoms small enough to interact with visible light, and the fabrication of metamaterials that can be detached from the hard surfaces they are developed on to be used in more ...

Recombination hotspot stacks the DNA deck in finding a new diabetes susceptibility gene

2010-11-04
November 4, 2010 – The autoimmune disease type 1 diabetes (T1D), also known as juvenile diabetes, is diagnosed in approximately 70,000 children worldwide per year. Genetics is increasingly being recognized as playing a significant role in susceptibility to the disorder, but outside a handful of genes, a clear understanding of the genetic architecture that underlies T1D has remained elusive. In a study published online today in Genome Research (www.genome.org), scientists have identified a novel gene associated with diabetes in mice that is revealing new clues about genomic ...

New compounds may treat both alcohol and cigarette addictions

2010-11-04
Researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco, and Pfizer Inc., have determined that two new compounds may be effective in treating both alcohol and nicotine dependence at the same time. In a paper published in the November 3, 2010 issue of Neuropsychopharmacology, the researchers showed that alcohol consumption in rodents was significantly decreased by two compounds that target neuronal nicotinic acetylcholine receptor (nAChR) subtype 34*. nAChRs are proteins found in the brain and broader ...

Moving holograms: From science fiction to reality

Moving holograms: From science fiction to reality
2010-11-04
Remember the Star Wars scene in which R2D2 projects a three-dimensional image of a troubled Princess Leia delivering a call for help to Luke Skywalker and his allies? What used to be science fiction is now close to becoming reality thanks to a breakthrough in 3D holographic imaging technology developed at the University of Arizona College of Optical Sciences. A team led by optical sciences professor Nasser Peyghambarian developed a new type of holographic telepresence that allows the projection of a three-dimensional, moving image without the need for special eyewear ...

LAST 30 PRESS RELEASES:

Students with multiple marginalized identities face barriers to sports participation

Purdue deep-learning innovation secures semiconductors against counterfeit chips

Will digital health meet precision medicine? A new systematic review says it is about time

Improving eye tracking to assess brain disorders

Hebrew University’s professor Haitham Amal is among a large $17 million grant consortium for pioneering autism research

Scientists mix sky’s splendid hues to reset circadian clocks

Society for Neuroscience 2024 Outstanding Career and Research Achievements

Society for Neuroscience 2024 Early Career Scientists’ Achievements and Research Awards

Society for Neuroscience 2024 Education and Outreach Awards

Society for Neuroscience 2024 Promotion of Women in Neuroscience Awards

Baek conducting air quality monitoring & simulation analysis

Albanese receives funding for scholarship grant program

Generative AI model study shows no racial or sex differences in opioid recommendations for treating pain

New study links neighborhood food access to child obesity risk

Efficacy and safety of erenumab for nonopioid medication overuse headache in chronic migraine

Air pollution and Parkinson disease in a population-based study

Neighborhood food access in early life and trajectories of child BMI and obesity

Real-time exposure to negative news media and suicidal ideation intensity among LGBTQ+ young adults

Study finds food insecurity increases hospital stays and odds of readmission 

Food insecurity in early life, pregnancy may be linked to higher chance of obesity in children, NIH-funded study finds

NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

New study reveals changes in the brain throughout pregnancy

15-minute city: Why time shouldn’t be the only factor in future city planning

Applied Microbiology International teams up with SelectScience

Montefiore Einstein Comprehensive Cancer Center establishes new immunotherapy institute

New research solves Crystal Palace mystery

Shedding light on superconducting disorder

Setting the stage for the “Frankfurt Alliance”

Alliance presents final results from phase III CABINET pivotal trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2024 and published in New England Journal of Medicine

X.J. Meng receives prestigious MERIT Award to study hepatitis E virus

[Press-News.org] Researchers discover new genetic factors associated with successful aging in the Amish
New findings on mitochondrial haplogroups and genetic variants that positively affect the aging process to be presented at ASHG 60th Annual Meeting in Washington, D.C.